Download
global medical marijuana mmj market to witness n.
Skip this Video
Loading SlideShow in 5 Seconds..
Medical Marijuana Market Report | Market Analysis 2018-2024 PowerPoint Presentation
Download Presentation
Medical Marijuana Market Report | Market Analysis 2018-2024

Medical Marijuana Market Report | Market Analysis 2018-2024

1 Views Download Presentation
Download Presentation

Medical Marijuana Market Report | Market Analysis 2018-2024

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. Global Medical Marijuana (MMJ) Market to witness a CAGR of 19.1% during 2018-2024 The global medical marijuana market is expected to grow significantly from USD 8,280.6 million in 2017 to USD 28,070.0 million in 2024, at a CAGR of 19.1% from 2018 to 2024. Factors propelling the growth of medical marijuana market are; growing awareness regarding the benefits offered, increasing demand for marijuana in the treatment of various diseases, and growing number of research and development activities. Moreover, several clinical trials are underway which are expected to drive the market demand over the years to come. The National Institute on Drug Abuse maintains detailed information on the therapeutic, as well as abusive aspects of marijuana. National Institutes of Health (NIH) provides funding to the researchers who are involved in exploring the therapeutic uses of medical marijuana. Recent studies have shown that marijuana extracts may be effective in the treatment of epilepsy. MMJ- offering business opportunity in the medical industry Medical marijuana plant contains many chemical properties that may help in treating a wide range of diseases and symptoms. The medical marijuana plant has two major strains: cannabis sativa and cannabis indica. These strains have various medical applications, which include treatment of muscle spasms, chronic pain, anxiety and sleep deprivation; control of nausea and vomiting, and stimulating appetite in AIDS patients. The industry size for medical marijuana is increasing primarily in the U.S., and creating an opportunity for market players to earn high profit margins. Global Medical Marijuana Market – Regional Insight North America held the largest share of the global medical marijuana market in 2017, and is expected to show exponential growth rate during the forecast period. The growth in the region is primarily driven by the growing number of the U.S states legalizing the use of marijuana in the medical applications. Europe held the second largest share in the global medical marijuana market in 2017. Growing importance of cannabis sector, coupled with several legalization initiatives is likely to augment the market growth in the region. Browse full research report with TOC on “Global Medical Marijuana Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024” at: https://www.energiasmarketresearch.com/global-medical-marijuana-market-outlook To purchase report: sales@energiasmarketresearch.com Key findings from the report: The global medical marijuana market is expected to reach USD 28,070.0 million by 2024 at CAGR of 19.1% from 2018-2024   Based on application, the chronic pain segment held the major share of the global market in 2017, due to presence of chemical compounds in marijuana which aid in relieving pain  Sativa type emerged as the largest segment in 2017, and is projected to maintain its dominance over the forecast period  On the basis of end-use, the pharmaceutical industry held the maximum share of the market in 2017. The increasing demand for MMJ from the pharmaceutical industry is due to its usage in developing new drugs for medical treatment of patients

  2. The key players operating in the medical marijuana market are Cannabis Sativa, Inc; GrowBlox Sciences, Inc.; GW Pharmaceuticals PLC; United Cannabis Corporation; Corbus Pharmaceuticals; Insys Therapeutics, Inc.; Lexaria Corporation; Canopy Growth Corporation; Growblox Sciences, Inc; Aurora Cannabis; AXIM Biotechnologies Inc.; Medical Marijuana, Inc.; Arena Pharmaceuticals; and Cara Therapeutics As of March 2018, GW Pharmaceuticals, announced receipt of Notices of Allowance for five new Epidiolex patent applications to be listed in the approved drug products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book), if the NDA for Epidiolex is approved. Once issued, these patents are set to expire in 2035. One or more patents may be eligible for additional patent term through patent term adjustment and/or regulatory exclusivities.  Read More :- https://www.energiasmarketresearch.com/global-medical-marijuana-market-size/ For any enquiry mail us at :- info@energiasmarketresearch.com